Protein N-glycosylation is an essential modification occurring in all eukaryotes and catalysed by the oligosaccharyltransferase (OST) of the endoplasmic reticulum. Comparative studies have clearly shown that eukaryotic STT3 proteins alone can fulfil the enzymatic requirements for Nglycosylation, yet in many cases STT3 homologues form stable complexes with a variety of noncatalytic OST subunits. Whilst some of these additional components may play a structural role, others appear to increase or modulate N-glycosylation efficiency for certain precursors. Here, we have analysed the roles of three non-catalytic mammalian OST components by studying the consequences of subunit-specific knockdowns on the stability and enzymatic activity of the OST complex. Our results demonstrate that OST48 and DAD1 are required for the assembly of both STT3A-and STT3B-containing OST complexes. The structural perturbations of these complexes we observe in OST48-and DAD1-depleted cells underlie their pronounced hypoglycosylation phenotypes. Thus, OST48 and DAD1 are global modulators of OST stability and hence Nglycosylation. We show that KCP2 also influences protein N-glycosylation, yet in this case the effect of its depletion is substrate-specific and characterised by the accumulation of a novel STT3A-containing OST subcomplex. Our results suggest that KCP2 acts to selectively enhance the OST dependent processing of specific protein precursors, most likely co-translational substrates of STT3A-containing complexes, highlighting the potential for increased complexity of OST subunit composition in higher eukaryotes.
Introduction
The diversity and complexity of the eukaryotic proteome is greatly enhanced by a variety of covalent modifications, and for proteins entering the secretory pathway the most prevalent of these is the addition of branched chain oligosaccharides to suitable asparagine residues. This N-linked glycosylation acts to recruit specific chaperones present in the lumen of the endoplasmic reticulum (ER) that promote protein folding, assembly and disulphide bond formation, contributes to the removal of misfolded glycoproteins, and influences protein trafficking through the secretory pathway (Aebi et al., 2010) . N-glycosylated proteins mediate numerous fundamental cellular processes, and defects in their production are linked to a variety of human diseases (Ohtsubo and Marth, 2006; Zelinger et al., 2011) . In eukaryotes, the process of protein N-glycosylation is catalysed by the oligosaccharyltransferase (OST), a membrane protein complex of the rough ER that transfers preassembled high-mannose oligosaccharides to asparagine residues present in the appropriate context, or sequon (N-x-S/T; x≠P), of a nascent polypeptide chain (Kelleher and Gilmore, 2006) . These N-sequons are efficiently modified when present in flexible and surfaceexposed segments of a polypeptide (Kowarik et al., 2006a; Lizak et al., 2011) . Interestingly, the bulk of protein N-glycosylation appears to occur in a co-translational manner; with the process coupled to ongoing protein synthesis at, and translocation into and across, the ER membrane (Harada et al., 2009; Ruiz-Canada et al., 2009) .
Whilst eukaryotes such as trypanosomatids and giardia are able to N-glycosylate newly synthesised polypeptides using a single-component enzyme, a member of the STT3 family (Castro et al., 2006; Izquierdo et al., 2009; Kelleher and Gilmore, 2006) , many eukaryotic OSTs consist of multiple subunits. The composition and subunit organisation of the mammalian enzyme is particularly complicated, having two homologues of Saccharomyces cerevisiae Stt3p, STT3A and STT3B.
STT3 proteins are the catalytically active components of the OST (Nilsson et al., 2003; Yan and Lennarz, 2002) and associate with a common set of non-catalytic subunits: ribophorin I (Ost1p in yeast), ribophorin II (Swp1p), OST48 (Wbp1p), DAD1 (Ost2p), N33 or IAP (Ost3p or Ost6p), and OST4 (Ost4p), generating two distinct OST isoforms in mammals (Kelleher et al., 2003) . The less enzymatically active, more selective STT3A isoform catalyses co-translational N-glycosylation, while the more active, less selective STT3B isoform can modify some sites skipped by STT3A and also mediate post-translational N-glycosylation of defined sequons (Ruiz-Canada et al., 2009 ).
Hence, as observed in Trypanosoma brucei (Izquierdo et al., 2009 ), it appears that different mammalian STT3 isoforms perform distinct but partially redundant roles, presumably ensuring optimal protein N-glycosylation of their respective substrates at the ER (Ruiz-Canada et al., 2009 ).
Many studies of non-catalytic OST subunits have used Saccharomyces cerevisiae as a model system , and mutations in several of these components, including Ost1p, Ost2p and Wbp1, result in reductions in N-linked glycosylation and in some cases destabilisation of the OST complex (Kelleher and Gilmore, 2006) . More recently, the Ost3p and Ost6p subunits have been shown to have disulphide oxidoreductase activity that may enhance the N-glycosylation of defined N-sequons by preventing the nascent polypeptide from prematurely forming disulphide bonds during co-translational N-glycosylation (Schulz et al., 2009 ). The contribution(s) of noncatalytic OST subunits to protein N-glycosylation in mammals is less well defined. Ribophorin I (the homologue of Ost1p) regulates the delivery of a subset of membrane proteins to the OST catalytic core (Wilson and High, 2007; Wilson et al., 2008) ; whilst ribophorin II is required for the efficient N-glycosylation of P-glycoprotein, although its precise contribution in this context is unclear (Honma et al., 2008) . Previous studies of DAD1, the mammalian equivalent of Ost2p, have relied solely on a temperature sensitive mutant (Kelleher and Gilmore, 1997; Sanjay et al., 1998) , and to date there have been no attempts at perturbing the function of mammalian OST48, the Wbp1 homologue. The identification of two novel OST subunits DC2 (or OSTC) and keratinocyteassociated protein 2 (KCP2) (Roboti and High, 2012; Shibatani et al., 2005) , present only in higher eukaryotes, adds to the potential mechanistic complexity of the enzyme in higher eukaryotes.
Whilst mammalian DC2 shows weak homology to S. cerevisiae Ost3p and Ost6p (Shibatani et al., 2005) , a search for conserved domains in KCP2 found no homology to known protein families.
Hence, the potential function of KCP2 during protein N-glycosylation is unclear (Kelleher and Gilmore, 2006; Roboti and High, 2012) , and lacking any experimental support (Wilson et al., 2011) .
In this study, we assess the contributions of three poorly characterised non-catalytic subunits to the structural and functional integrity of mammalian OST complexes. OST48, DAD1, or KCP2 were each knocked down using a small interfering RNA (siRNA) approach and the effects of these treatments on the stability of a range of individual OST subunits was investigated. We have also addressed the contribution of these three subunits to the stability of native OST complexes, and determined the effect of their knockdown upon the N-glycosylation of a small set of model substrates using two different approaches. We show that OST48 and DAD1 have a major role in stabilising both STT3A-and STT3B-containing OST complexes; hence their depletion results in a severe and global hypoglycosylation phenotype that is directly comparable to that seen upon the depletion of both catalytic STT3 proteins. Our studies of KCP2 reveal that it is essential for the formation of the major STT3A-containing OST complex, and we show that KCP2 acts to facilitate N-glycosylation in a substrate-specific manner, underlining the additional complexity of the process in higher eukaryotes.
Results

OST48 and DAD1 are required for the stability of both catalytic STT3 proteins
We first assessed the effect of knocking down previously defined OST components on the steadystate levels of the catalytic STT3A and STT3B subunits and vice versa. Triton X-100 extracts of HeLa cells, prepared 72 h after transfection with siRNAs specific for a particular OST subunit, were analysed by quantitative immunoblotting (Fig. 1 and Table 1 ). OST48 siRNA treatment markedly decreased OST48 levels by ∼ 4-fold, resulting in ∼ 2-fold reduction of both STT3A and STT3B and a substantial destabilisation of DAD1 and KCP2 (Fig. 1A , cf. lanes 1 and 4; for quantification see Fig. 1B and Table 1 ). Depletion of DAD1 (~ 7-fold reduction) led to a 2-to 3-fold decrease in STT3A, STT3B, and OST48, and a ∼ 6-fold reduction of KCP2 (Fig. 1A , cf. lanes 1 and 5; Fig. 1B and Table 1 ). Various siRNAs targeting KCP2 were tested and we found one to be extremely effective at knocking down KCP2 protein levels (> 10-fold reduction; Fig. 1A, αKCP2 panel, cf. lanes 1, 6, and 7). In contrast to the OST48 and DAD1 knockdowns, this KCP2 siRNA did not affect the stability of STT3A, STT3B, or OST48, although we did see a modest reduction in DAD1 levels (Fig. 1A , cf. lanes 1 and 6; Fig. 1B and Table 1 ).
The STT3A siRNA substantially reduced STT3A protein levels (~ 7-fold decrease), also resulting in a ~ 2-fold loss of OST48 and DAD1, and an even more striking reduction in KCP2 levels (Fig.   1A , cf. lanes 1 and 2; Fig. 1B and Table 1 ). Importantly, pronounced destabilisation of KCP2 was also observed with a second siRNA targeting STT3A (siSTT3A #2; see Supplementary material, Fig. S1 ), and after knocking down STT3A in HepG2 cells (see Fig. 1C ), thereby ruling out offtarget or cell type-specific effects. On this basis, the reduction of KCP2 we observe in OST48-and DAD1-depleted cells may actually reflect the significant loss of STT3A resulting from these treatments. Conversely, the efficient knock down of KCP2 had no effect on STT3A levels, and in fact only DAD1 levels showed a significant change displaying a modest reduction (Fig. 1B and Table 1 ). As previously observed, knockdown of STT3A had little effect on STT3B (Ruiz-Canada et al., 2009) . In contrast, the siRNA-mediated 3-fold reduction of STT3B led to a marked increase in STT3A levels (cf. Ruiz-Canada et al., 2009 ), but reduced DAD1 by 2-fold with modest effects on OST48 and KCP2 levels (Fig. 1A , cf. lanes 1 and 3; Fig. 1B and Table 1 ). Destabilisation of these OST subunits did not noticeably affect the steady-state levels of the α-subunit of the ER resident Sec61 translocon complex (Fig. 1A, αSec61α panel; cf. Ruiz-Canada et al., 2009; Sanjay et al., 1998) . Taken together, the mutual destabilisation of multiple OST subunits upon the siRNA-mediated reduction of individual non-catalytic components is consistent with the loss of certain subunits perturbing the complex as a whole.
In order to rule out any loss of OST components resulting from the Triton X-100 extraction procedure we used to prepare the cell extracts, we also analysed whole cell lysates resulting from direct solubilisation in SDS sample buffer (Supplementary material, Fig. S2A,B) . The effects of the various siRNA treatments upon the five OST subunits analysed are comparable using both approaches (cf. Fig. 1B and Fig. S2C ). The only exception is that we no longer observe an increase in STT3A signal following STT3B depletion. This is in contrast to both our data using the Triton X-100 approach, and an independent study that analysed digitonin-high salt extracts following siRNA-mediated depletions (Ruiz-Canada et al., 2009) . It is worth noting that the levels of STT3A present in HeLa cells appear much lower than other OST subunits including STT3B (Roboti and High, 2012) , and this may be reflected in the sensitivity of its detection. We also investigated the possibility of a linkage between OST subunit expression at the mRNA level rather than via the costabilisation of individual protein subunits. The OST48 and DAD1 proteins appear to be the most sensitive to the depletion of other OST subunits (see Table 1 ); hence, we used RT-PCR to analyse the levels of their mRNAs following the knockdown of each of the five subunits under study. N-glycosylation enhances protein folding and degradation of non-native polypeptides (Aebi et al., 2010) ; hence any perturbation of this process might increase levels of aberrant proteins, resulting in an unfolded protein response (UPR) (Ron and Walter, 2007) . We examined the inositol-requiring protein-1 (IRE1) branch of the UPR after OST subunit knockdown, but found no evidence for any X-box binding protein-1 (XBP1) mRNA splicing indicative of ER stress (Supplementary material, Fig. S4 ). We conclude that despite efficient knockdowns of several individual components, either the residual OST activity is sufficient to cope with the cellular requirement for N-glycosylation under our experimental conditions and/or there is substantial functional redundancy between the distinct mammalian OST complexes containing STT3A or STT3B (cf. Ruiz-Canada et al., 2009 ); see also below).
OST48 and DAD1 are required for the oligomeric assembly of native OST isoforms
To test the hypothesis that the wide-ranging effects of OST48 or DAD1 depletion ( Fig. 1 Fig. 2A) . As previously revealed in our studies using HepG2 cells (Roboti and High, 2012) , STT3A was primarily detected in a ∼ 500 kDa complex (OSTC500; Fig. 2A, lane 3) while STT3B was present in a larger complex(es) of ∼ 520-580 kDa (OSTC550; Fig. 2A, lane 4) . On the basis of co-migration, both OSTC500 and OSTC550 appear to contain OST48 and DAD1 ( Fig. 2A , lanes 5 and 6). A substantial amount of KCP2 appears to be present in the STT3A-containing isoform OSTC500, consistent with previous evidence of a physical association (Roboti and High, 2012) . Some KCP2 may also be present in a larger complex that co-migrates with STT3B-containing OSTC550 species (Fig. 2A , lane 2; see also Roboti and High, 2012) .
Digitonin-solubilised homogenates were prepared from siRNA-treated HeLa cells (cf. Ruiz-Canada et al., 2009 ) and standard immunoblot analysis following SDS-PAGE confirmed the relevant knockdowns (Fig. 2B ). The immunoblot analysis of discrete OST complexes, resolved by BN-PAGE using an antibody specific for STT3A, revealed an almost complete loss of the OSTC500 species in cells with siRNA-mediated reductions in the levels of STT3A, OST48, and DAD1 ( Fig.   2C , αSTT3A panel, cf. lanes 1, 2, 5, and 6). In contrast, the OSTC500 appeared unaffected by STT3B depletion (Fig. 2C, αSTT3A panel, cf. lanes 1 and 3, 4). Intriguingly, reduced KCP2 levels led to a loss of OSTC500 species with the concurrent appearance of a faster-migrating, STT3A-containing species denoted OSTC470 (Fig. 2C, αSTT3A panel, cf. lanes 1 and 7, open circle). Very low levels of STT3B-containing OSTC550 were observed in cells knocked down for STT3B, OST48, and DAD1 (Fig. 2C, αSTT3B panel, cf. lanes 1, 3, 4, and 5). In contrast, depletion of STT3A or KCP2 had no obvious effect on these species (Fig. 2C, αSTT3B panel, cf. lanes 1, 2, and 6).
Analysis of both OST48-and DAD1-containing species further validated the results detailed above, revealing a pronounced reduction in the levels of both OSTC500 and OSTC550 after depletion of OST48 or DAD1 (Fig. 2C , αOST48 and αDAD1 panels, cf. lanes 1, 4, and 5) and the appearance of a OSTC470-like species in KCP2-knockdown cells (Fig. 2C, αOST48 and αDAD1 panels, lane 6, open circles). A comparable ∼ 470 kDa species containing low levels of OST48 and DAD1 is also apparent in control and STT3B-knockdown cells (Fig. 2C, αOST48 and αDAD1 panels, lanes 1 and 3, cf. open circles). Most likely our antibody against STT3A is unable to detect this comparatively low-abundance species in the absence of KCP2 knockdown (cf. Fig. 2C , αSTT3A panel, lanes 1, 3, 4, and 7), and we conclude OSTC470 is an STT3A-containing OST subcomplex that lacks KCP2 (cf. Roboti and High, 2012) . Reprobing of the immunoblots showed that depletion of the OST subunits did not affect the steady-state levels of the physically adjacent Sec61 translocon complex (Sec61C; see Supplementary material Fig. S5 ), confirming the localised effects of OST subunit loss. In terms of the discrete OST complexes detectable by BN-PAGE analysis, the knockdown of OST48 and DAD1 perturbs complexes containing both STT3 isoforms.
In contrast, the knockdown of individual STT3 isoforms selectively perturbs only OST complexes containing the target isoform, whilst the knockdown of KCP2 results in a mobility shift of the major STT3A-containing complex and has no visible effect upon the STT3B-containing species.
OST48, DAD1, and KCP2 facilitate protein N-glycosylation in vitro
Having established that the depletion of individual OST subunits appears to be accompanied by distinct effects on the structural integrity of the whole complex, an in vitro analysis of the functional consequences of these various subunit depletions was performed. HeLa cells were knocked down for the relevant OST subunit, semi-permeabilised with digitonin, and the Nglycosylation capacity of the ER of these preparations was then analysed using a well-established cell-free system (Wilson and High, 2007) . Aquaporin 1 (AQP1) is a channel-forming protein with a complex membrane topology, and the polypeptide chain is known to be exclusively N-glycosylated at Asn-42 (Supplementary material Fig. S6A ). When its biogenesis was analysed using the cell free system, a ∼ 50% reduction in the level of N-glycosylated AQP1 (AQP1-1) was observed in STT3A-depleted cells, whilst depletion of STT3B resulted in a ∼ 25% reduction (Fig. 3A) .
Strikingly, the knockdown of OST48 or DAD1 led to a greater than 70% reduction of Nglycosylation in a parallel analysis (Fig. 3A) . Collectively, these results suggest that the single Nsequon in AQP1 can be modified by STT3A and to a lesser extent by STT3B, emphasising their overlapping roles (Ruiz-Canada et al., 2009) . The even more pronounced inhibitory effects of OST48 and DAD1 knockdowns that we observe are consistent with the disruption of both OST isoforms following these treatments. Intriguingly, KCP2 depletion resulted in a ∼ 25% reduction in the levels of N-glycosylated AQP1 (Fig. 3A) , providing the first evidence that KCP2 plays any functional role during this process. We ascribe this contribution of KCP2 to substrates utilising STT3A-containing OST complexes for their N-glycosylation (see below).
Prepro-alpha-factor (ppαF) is a yeast secretory glycoprotein with a cleavable signal sequence and three sites for N-glycosylation (Supplementary material Fig. S6B) . A modest decrease in the levels of fully glycosylated pαF (pαF-3) was observed in STT3A-, STT3B-, and KCP2-knockdown cells, and this was accompanied by an increase in non-glycosylated species consistent with these subunits contributing to OST activity (pαF-0; Fig. 3B ). In contrast, although the levels of pαF-3 were not significantly affected by the OST48 or DAD1 knockdowns, the levels of pαF species lacking one N-glycan (pαF-2) were visibly increased, especially by the OST48 siRNA treatment (Fig. 3B) , indicating hypoglycosylation. Asialoglycoprotein receptor (ASGPR) is a type II membrane protein with two N-glycosylation sequons (Supplementary material Fig. S6C ). In this case, the individual knockdown of the two catalytic STT3 subunits had no measurable effect on the levels of fully glycosylated ASGPR (ASGPR-2; Fig. 3C ), suggesting substantial redundancy of the different mammalian OST complexes for modification of this precursor. Intriguingly, normal glycosylation of ASGPR was also detected after KCP2 depletion (Fig. 3C) , indicating any role of this component in relation to protein N-glycosylation may be precursor-specific. Conversely, depletion of OST48 or DAD1 again resulted in the appearance of intermediates lacking one Nglycan (ASGPR-1; Fig. 3C ), as previously observed with pαF (Fig. 3B) . Furthermore, we also observed a similar effect when we studied a second type II membrane protein, the invariant chain (Ii) of the major histocompatibility complex (MHC) class II, using the same approach (Supplementary material, Fig. S7 ). Taken together, the clearly visible accumulation of hypoglycosylated species observed upon the depletion of OST48 and DAD1 (Fig. 3B,C and Supplementary material, Fig. S7 ; cf. Silberstein et al., 1995; te Heesen et al., 1992) are entirely consistent with the functional perturbation of OST complexes containing both STT3 isoforms (cf.
Figs 1, 2; also see Discussion).
Lastly, opsin, a polytopic membrane protein with two N-sequons (Supplementary material, Fig.   S6D ) was analysed. In this case, evidence for alterations at the qualitative level were far less obvious than for the other precursors with no hypoglycosylated forms apparent (Fig. 3D ).
Quantification showed that any potential changes in N-glycosylation were not statistically significant, and we conclude that the effects of OST subunit depletion detected using our in vitro assay are substrate-specific. Overall, our in vitro analysis suggests that OST48, DAD1, and KCP2 can all facilitate N-glycosylation in a substrate-specific manner. Notably, in every case we found that the effect of tunicamycin treatment of cells was more pronounced than the knockdown of any of the OST subunits analysed here, including either of the two mammalian STT3 isoforms (Fig. 3) .
We conclude that although both quantitative immunoblotting of individual OST subunits and BN gel analysis of OST complexes indicate substantial siRNA-mediated perturbation, the residual OST activity is present in relative excess compared to the low levels of substrates that are synthesised in vitro.
OST48, DAD1, and KCP2 are required for efficient N-glycosylation in HeLa cells
In order to further explore the effects of OST subunit depletion, we next adopted a cell-based system to study two previously characterised glycoproteins (Ruiz-Canada et al., 2009 ). Firstly, human coagulation factor VII (FVII) was transiently expressed in HeLa cells, and its biosynthesis and N-glycosylation analysed by pulse labelling. After a 10 min pulse of radiolabel, fully glycosylated (FVII-2) and mono-glycosylated (FVII-1) species were readily apparent, but only a trace of non-glycosylated (FVII-0) species was seen ( Fig. 4A and Fig. 4B, lane 2) . The most striking effects were observed upon depletion of STT3A, OST48, and DAD1, and in each case the levels of FVII-0 were noticeably increased, whilst FVII-2 levels was decreased and FVII-1 levels not significantly affected (Fig. 4B , cf. lanes 2, 3, 5, and 6). In contrast, depletion of STT3B or KCP2 had no statistically significant effect in this assay (Fig. 4B , cf. lanes 2, 4 and 7). Prosaposin (pSAP) is an abundant endogenous glycoprotein of HeLa cells (Ruiz-Canada et al., 2009 ) and the early stages of its biosynthesis were also studied by pulse labelling. In control cells, the predominant form of pSAP recovered is the fully-glycosylated form (Fig. 4C and Fig. 4D , lane 2, pSAP-5), whilst tunicamycin treatment effectively prevented any N-glycosylation to yield nonglycosylated pSAP (Fig. 4D, cf. lanes 1 and 2, pSAP-0) . As for exogenously expressed FVII, depletion of STT3A, OST48, or DAD1 resulted in a substantial perturbation of pSAP N-glycosylation, whilst reduction of STT3B had little, if any, effect (Fig. 4D, cf. lanes 2-6) . In each case, the reductions in the level of pSAP-5 were accompanied by increases in hypoglycosylated species (Fig. 4D , pSAP -2, -3, and -4; see also quantification). Strikingly, depletion of KCP2 also had a clear effect on pSAP N-glycosylation, in this case reducing pSAP-5 levels and increasing pSAP-4 species (Fig. 4D, cf . lanes 2 and 7; see also quantification). On this basis, we conclude that OST48, DAD1, and KCP2 all contribute to the efficient N-glycosylation of pSAP. Given the effects of STT3A and STT3B depletion are comparable to those previously reported (cf. RuizCanada et al., 2009), we believe that these data most likely reflect the contributions of these noncatalytic subunits to the STT3A-dependent co-translational processing of pSAP (see below).
Whilst STT3A-containing OSTC500 species appear to be a major site for co-translational Nglycosylation, STT3B-containing OSTC550 species may perform overlapping functions, resulting in at least partial redundancy (Ruiz-Canada et al., 2009) . Hence, the hypoglycosylation of pSAP we observe upon depletion of OST48, DAD1 or KCP2 might either be a direct reflection of reduced OSTC500 function or the result of pSAP being shunted into an alternative, OSTC550-mediated route. To further address this issue we looked at combinations of double knockdowns using pSAP N-glycosylation as a read-out. As expected, the depletion of both STT3A and STT3B had a more pronounced effect than a reduction of STT3A alone (Fig. 5, cf. lanes 1, 2, and 4) . Compellingly, this combination mirrored the depletion of OST48 alone (Fig. 5 , cf. lanes 4 and 5), supporting our proposal that reductions in OST48 levels perturb both classes of OST complex, i.e. those containing STT3A and those containing STT3B. This is consistent with the destabilisation of both OSTC500 and OSTC550 species we see upon OST48 knockdown (Fig. 2) . The pronounced effect of OST48 reduction (Fig. 5, cf . lanes 1 and 5) may also reflect a role in supplying lipid-linked oligosaccharide donors to the active site of OST complexes (cf. Kelleher et al., 2007) . In contrast, co-depletion of DAD1 and OST48 is comparable to OST48 depletion alone (Fig. 5, cf . lanes 5 and 9), presumably since the loss of OST48 results in a substantial loss of DAD1 (Table 1) .
Although our data suggest that co-depletion of STT3B with OST48 or DAD1 may have a modest corrective effect (Fig. 5 , lanes 5-8; see also quantification), in practice this effect most likely reflects the up-regulation of STT3A expression resulting from STT3B depletion ( Fig. 1 and Table   1 ; see also Ruiz-Canada et al., 2009 ). In the light of the distinct combinatorial effects of STT3B depletion with STT3A, OST48, or DAD1 that we observe, the absence of any additional effect of STT3B depletion in combination with the KCP2 knockdown (Fig. 5, cf. lanes 10 and 11) is very informative. Our previous work had shown a physical link between STT3A and KCP2 (Roboti and High, 2012) that we have gone on to extend in this study (Figs 1, 2) . Furthermore, we see clear evidence that KCP2 is required for the efficient N-glycosylation of many, but not all, precursors (Figs 3, 4) . In comparison to the co-depletion of STT3A and STT3B, the absence of any additional defect in pSAP N-glycosylation upon co-depletion of KCP2 and STT3B strongly suggests that loss of KCP2 perturbs OSTC500 activity in a way that cannot be compensated for by the OSTC550 species (see Fig. 6 ).
Discussion
Although the effect of siRNA-mediated depletions of several mammalian OST subunits have been reported in recent years, our data provides the first analysis of OST48 and DAD1 function using this technique. At the level of its individual subunits, we see clear evidence for the mutual stabilisation of components of the OST, consistent with their assembly into a discrete complex(es).
Hence, in terms of OST subunit stability, the consequences of the siRNA-mediated depletion of an individual non-catalytic component, in this case OST48 or DAD1, are at least as severe as the knockdown of the catalytic subunits. By these criteria, the behaviour of KCP2 is distinct. Hence, whilst KCP2 depletion has a marginal effect on the levels of other OST subunits, its own stability is strongly dependent on the presence of each of the other OST subunits tested, with the clear exception of STT3B. These data are entirely consistent with the original suggestion that KCP2 is a subunit of the mammalian OST complex (Shibatani et al., 2005) , and strongly support our own contention that it is primarily associated with OST complexes containing the STT3A isoform (Roboti and High, 2012) . Furthermore, since KCP2 lacks N-linked glycans (Roboti and High, 2012) , this effect cannot be mediated by its inefficient glycosylation in HeLa cells depleted for other OST subunits. Interestingly, this apparently one-way stabilisation displayed between STT3A and KCP2 is comparable to the relationship between other ER membrane protein assemblies, such as the HRD1-SEL1L ubiquitin ligase complex (Iida et al., 2011) . In the round, these data highlight the role of multiple non-catalytic subunits in stabilising the two classes of mammalian OST complexes, and show that this role is not restricted to DAD1 (Sanjay et al., 1998) By using BN-PAGE combined with immunoblotting we were able to consider the effect of depleting individual OST subunits upon the stability of discrete OST complexes containing one or other of the two catalytic STT3 subunits that we previously defined in HepG2 cells (Roboti and High, 2012) . Most significantly, we observe that the depletion of either of the DAD1 or OST48 has an even more pronounced destabilising effect on global OST complex stability than the individual knockdown of either catalytic STT3 isoform alone. Hence, we conclude that mammalian OST48 and DAD1 are important for the stability of two distinct classes of OST complexes that contain either STT3A or STT3B (see Fig. 6 ). In fact, our data also indicate that the OST48 and DAD1 subunits stabilise each other (see Table 1 ), consistent with both the previous study of a temperature-sensitive version of DAD1 (Sanjay et al., 1998) and evidence for a direct interaction between these two components (Kelleher and Gilmore, 1997). However, although this means that we cannot easily ascribe a more important role in OST complex stability to one or other of these two subunits, the more pronounced effect of their depletion upon global OST complex stability is readily apparent. Furthermore, the yeast homologues of both OST48 (Wbp1p) and DAD1 (Ost2p) are known to be essential for cell viability (Silberstein et al., 1995; te Heesen et al., 1992) , underpinning the suggestion that these components play a central role in maintaining the structural integrity of mammalian OST complexes. Although we favour a model where the siRNA depletion of one subunit results in the degradation of other protein subunits by destabilising the OST complex, additional levels of regulation, such as feedback loops that influence the translation of mRNAs encoding other OST subunits (Mick et al., 2010) , may also contribute to their loss.
In contrast to all of the other OST subunit knockdowns that we analysed by BN-PAGE and immunoblotting, the effect of KCP2 depletion upon detectable OST complexes was comparatively mild. In the case of the STT3B-containing OST complexes (OSTC550), we saw no effect, supporting our model that KCP2 is predominantly incorporated into STT3A-containing complexes (Roboti and High, 2012) . In contrast, loss of KCP2 appears to prevent the complete assembly of OSTC500, resulting in the accumulation of an STT3A-containing OST subcomplex (cf. Roboti and High, 2012; Shibatani et al., 2005; Wang and Dobberstein, 1999 ). Since we do not have good quality antibodies for all known mammalian OST subunits, the discrete OSTC470 species observed upon KCP2 depletion may also lack additional, as yet unidentified, components. Nevertheless, these results suggest that the assembly of the major OSTC500 species detectable after BN-PAGE could arise via the recruitment of KCP2 to a smaller subcomplex (OSTC470) that contains at least STT3A, OST48 and DAD1, and most likely other known subunits of the mammalian OST.
Overall, our in vitro analysis of OST function indicates that OST48, DAD1, and KCP2 facilitate Nglycosylation in a precursor-specific manner. The comparatively mild phenotype observed in OST subunit-depleted cells (cf. tunicamycin treatment) most likely reflects residual OST activity after siRNA treatment. We typically observed more severe N-glycosylation defects in OST48-and DAD1-depleted cells than in cells treated with the STT3A or STT3B siRNA alone. These data are consistent with a model where the loss of these two non-catalytic subunits destabilises both STT3A-and STT3B-containing OST complexes and thereby more effectively inhibits Nglycosylation (see Fig. 6 ). Interestingly, AQP1 proved to be the most sensitive substrate for perturbations of OST-mediated protein N-glycosylation using our in vitro assay. This most likely reflects the fact that the glycosylation of Asn-42 of AQP1 is complex, and relies on the initial translocation of TM2 into the ER lumen prior to the subsequent topological maturation of the precursor into its final structure (Buck et al., 2007; Foster et al., 2000) . Our studies of protein Nglycosylation using a cell-based system bear out this model. Thus, the N-glycosylation of both FVII and pSAP was quantitatively less efficient after knocking down OST48 than STT3A, whilst knocking down STT3B had no detectable effect (cf. Ruiz-Canada et al., 2009) . Furthermore, the knockdown of KCP2 resulted in a mild yet specific perturbation of pSAP N-glycosylation, confirming the effect of KCP2 depletion we observed in vitro and showing that KCP2 is a bone fide functional component of the mammalian OST. Although a recent study concluded that KCP2 is dispensable for mammalian OST activity, only one authentic protein substrate was analysed in vitro (Wilson et al., 2011) . We now provide the first evidence that KCP2 levels influence protein N-glycosylation in a substrate-specific manner, with the most striking effect observed upon the biogenesis of endogenous pSAP in HeLa cells.
KCP2 depletion is the only treatment that results in an altered OSTC species rather than a loss of detectable OST complexes. On this basis, we conclude that the majority of pSAP N-glycosylation occurs via the STT3A-containing OSTC470 species following KCP2 knockdown, and speculate that although these KCP2-depleted OSTs are suboptimal, nascent pSAP polypeptides are still modified here in preference over the alternative STT3B-containing OSTC550 species (Fig. 6) . Hence, when we co-deplete KCP2 and STT3B we see no additional defect in pSAP N-glycosylation. In contrast, when we co-deplete STT3A and STT3B, the hypoglycosylation phenotype of pSAP is comparable to that of depleting OST48 alone (cf. Fig. 6 ). In contrast to the role of other non-catalytic OST subunits (Schulz et al., 2009; Wilson et al., 2008) , the precise contribution of KCP2 during protein N-glycosylation remains to be established. However, given KCP2 appears to function primarily, if not exclusively, in combination with the STT3A isoform (Roboti and High, 2012 ; see also this study), it seems likely that the role of KCP2 relates to the co-translational modification of nascent polypeptide chains. Furthermore, the most significant defect resulting from KCP2 depletion appears to be an increase in forms of pSAP lacking one of the five N-linked glycans normally attached (i.e. less pSAP-5 and more pSAP-4; see Fig. 4D ); a phenotype that is quite distinct from that of the other siRNA depletions. On this basis, we speculate that KCP2 may preferentially facilitate the N-glycosylation of a particular N-sequon within the nascent pSAP chain (cf. Fig. 4C ).
Alternatively, the alteration in pSAP N-glycosylation we observe upon KCP2 depletion may simply reflect a stochastic reduction in the occupancy of all five potential sites averaged across the whole population of polypeptides synthesised during our analysis. At an organismal level, our study is consistent with the suggestion that there may be some correlation between increases in the complexity of OST subunit composition and the diversity of protein substrates and N-sequons that the resulting complex is capable of modifying (Kowarik et al., 2006b ). Indeed, higher eukaryotes seem to have acquired additional non-catalytic subunits, as exemplified by KCP2, that are over and above known and predicted homologues of the well-defined yeast OST subunits (Kelleher and Gilmore, 2006; Shibatani et al., 2005) . Conversely, various kinetoplastid single-component OSTs display the capacity to N-glycosylate an array of substrates (Castro et al., 2006; Izquierdo et al., 2009; Kelleher and Gilmore, 2006; Nasab et al., 2008) . Thus, the idea that OST complexity directly reflects substrate complexity may be over simplistic, and non-catalytic OST subunits may perform other roles that remain to be delineated.
Materials and Methods
Cell culture and transfection
All siRNAs used in this study were custom synthesised by QIAGEN and their sense strand sequences are in Table S1 in supplementary material. QIAGEN AllStars non-targeting siRNA was used as a negative control. HeLa and HepG2 cells were grown in DMEM supplemented with 10% FBS and 2 mM L-glutamine at 37ºC under 5% CO 2 . Approximately 2.6 × 10 5 HeLa cells were seeded in 10 cm dishes 24 h before transfection with siRNA duplexes (see Table S1 
Immunoblotting
Cells were solubilised at 4°C by a 1 h incubation with Triton X-100 lysis buffer containing 10 mM Tris-HCl pH 7.6, 140 mM NaCl, 1 mM EDTA, 1% Triton X-100, and a protease inhibitor cocktail.
Cell extracts were clarified by centrifugation and soluble proteins were quantified using the BCA Protein Assay kit (Pierce). Proteins (~ 30 μg) were separated by SDS-PAGE and analysed by infrared immunoblotting (Roboti and High, 2012) . Alternatively, cells were directly solubilised in SDS-sample buffer (0.1 M Tris-HCl pH 6.8, 5 mM EDTA, 0.5 M sucrose, 0.5% L-methionine, 0.01% bromophenol blue, 40 mM DTT, 3% SDS) and equal volumes subjected to SDS-PAGE and infrared immunoblotting. Antibodies against STT3A, STT3B, OST48, DAD1, and KCP2 have been previously described (Roboti and High, 2012) . Antisera recognising α-tubulin and Sec61α
were from Keith Gull (University of Oxford, UK) and Richard Zimmermann (Saarland University, Germany), respectively. Fluorescent-labelled secondary antibodies were purchased from LI-COR Biosciences (Cambridge, UK). The fluorescent bands were visualised and quantified on the Odyssey Infrared Imager (LI-COR Biosciences) using the software provided by the manufacturer.
Semi-quantitative RT-PCR analyses
After 72 h of siRNA-treatment, HeLa cells were harvested in Trizol (Invitrogen) and total RNA was extracted according to the manufacturer's instructions. RNA (1 μg) was reverse-transcribed into single-stranded cDNA using the AMV-RT system (Roche). One-eighth and one-sixteenth of the synthesised cDNA was used as template for PCR amplification of XBP1 and OST48 or DAD1 mRNAs, respectively. A standard PCR protocol using Taq polymerase and human specific primers for Xbp1 (forward: 5′-ACAGCGCTTGGGGATGGATG-3′; reverse: 5′-TGACTGGGTCCAAGTTGTCC-3′), OST48 (forward: 5′-CACCTTAGTGCTGCTGGACA-3′;
reverse: 5′-CGAAGGGGAGAAAATGATGA-3′), DAD1 (forward: 5′-GTTATGTCGGCGTCGGTAGT-3′; reverse: 5′-ACAAGAGATGAAGCCCGAGA-3′) was followed. Parallel amplifications with primers for GAPDH cDNA (forward: 5′-GACCCCTTCATTGACCTCAACTACATG-3′; reverse: 5′-GTCCACCACCCTGTTGCTGTAGCC-3′) were performed. The numbers of cycles (between 25 and 31) giving the linear range were adjusted depending on the genes amplified. PCR products were resolved on 2% agarose gels and visualised on a UV transilluminator. Band intensities were quantified using AIDA v3.52 image-analyser software (Raytest).
BN-PAGE
BN-PAGE was based on the protocol of Wittig et al. (2004) . Twenty passes through a ball-bearing homogeniser (10 μm clearance) was used to homogenise ∼ 25 mg of sedimented siRNA-treated HeLa cells in 500 μl sucrose buffer (83 mM sucrose, 6.6 mM imidazole-HCl pH 7.0). The pellet obtained from 80 mg wet weight homogenised cells were solubilised in 35 μl solubilisation buffer (50 mM NaCl, 2 mM 6-aminohexanoic acid, 1 mM EDTA, 50 mM imidazole-HCl pH 7.0) containing 1% digitonin for 20 min at 4ºC. Insoluble material was removed by centrifugation at 16,000 × g for 10 min at 4°C, and the supernatant was mixed with 1/8 volume of 50% glycerol and 1/40 volume of 5% (w/v) Coomassie Blue G250 (Serva) in 500 mM 6-aminohexanoic acid.
Samples were run on a 4-10% polyacrylamide gradient gel as described previously (Roboti and High, 2012) and then analysed by immunoblotting.
Metabolic labelling and immunoprecipitation
Cells were starved in a methionine-and cysteine-free DMEM (GIBCO) supplemented with 2 mM L-glutamine for 20 min at 37ºC, and then incubated in fresh starvation medium containing 22 μCi/ml [ 35 S]Met/Cys protein labelling mix (PerkinElmer; specific activity >1,000 Ci/mmol) for 10 min. Tunicamycin (Calbiochem) was added at a final concentration of 10 μg/ml ∼ 20 h prior to the starvation and was also included throughout the starvation and pulse. Cells were washed twice with PBS and solubilised with Triton X-100 lysis buffer. Clarified lysates were denatured with 1% SDS at 37ºC for 30 min, then diluted 5-fold with Triton X-100 lysis buffer containing 8 mM cold
Met/Cys and 1 mM PMSF, and pre-cleared by incubation with pansorbin (Calbiochem) at 4°C for 1 h. The pre-cleared lysates were incubated overnight with antibodies specific for either saposin D (Konrad Sandhoff, University of Bonn, Germany) or FVII (R&D Systems), and immune complexes were captured using Protein A-Sepharose beads (GenScript, USA). Beads were washed three times with Triton X-100 buffer before eluting proteins with SDS-PAGE sample buffer.
Samples were denatured at 37°C for 1 h, resolved by SDS-PAGE, and analysed by phosphorimaging (FLA-3000; Fuji). 
In vitro glycosylation assay
siRNA-treated cells were semi-permeabilised (Wilson et al., 1995) and used as a source of ER membranes for in vitro translation. Briefly, the plasma membrane was permeabilised with KHM buffer (110 mM KOAc, 20 mM HEPES pH 7.2, and 2 mM MgOAc) supplemented with 40 μg/ml digitonin (Calbiochem) on ice for 5 min. 
Data and statistical analysis
Data are expressed as means ± SEM, and two-tailed t tests were performed to determine p values for paired samples using Prism 4 (GraphPad). Figure 2C were reprobed with an antibody against Sec61α to control for loading. OSTC550, OSTC500, OSTC470, and the Sec61α-containing complexes (Sec61C) are indicated. Landolt-Marticorena and Reithmeier, 1994; Nilsson and von Heijne, 1993; Popov et al., 1997) . Thus, the Asn-205 site in AQP1 is inaccessible to the OST (dashed red structure; see Skach et al., 1994) and Asn-42 is not efficiently modified in vitro (Foster et al., 2000) . 
Figure Legends
